Orkla Health Acquires NutraQ from Impilo

KKR and Impilo Acquire Immedica Pharma

January 24, 2025

Pharmaceuticals

KKR and Nordic healthcare investor Impilo have completed a joint acquisition of Stockholm-based Immedica Pharma, with Immedica management reinvesting alongside the new owners. Immedica is a commercial-stage pharmaceutical company focused on rare and specialty diseases (notably hematology, oncology and genetic/metabolic disorders) with ~€100m revenue and more than 120 employees; CVC Credit provided debt financing and Impilo used a single-asset continuation fund supported by secondary investors.

Impilo Acquires Majority Stake in tandlægen.dk

January 1, 2022

Dental

Impilo, a Nordic healthcare-focused investment company, has acquired a majority stake in tandlægen.dk, Denmark’s leading dental clinic chain. The clinic leaders and management have reinvested part of their proceeds and will partner with Impilo to support further growth, quality improvements and digitalisation across the chain’s 52 clinics and ~800 employees.

Summa Equity Acquires Majority Stake in Nutris

September 3, 2024

Food & Beverage

Impact investor Summa Equity has acquired a majority stake in Nutris, a Croatian plant-based protein ingredients manufacturer founded in 2019. The investment will support scaling Nutris’s manufacturing capacity and R&D to expand production of fava-bean protein isolates and other plant-based ingredients for food, sports nutrition and dairy/meat alternative markets.

Quest Products (Promus Equity) Acquires OraHealth Corporation

January 9, 2019

Consumer Products

Promus Equity Partners’ portfolio company Quest Products has merged with OraHealth Corporation to acquire the OraCoat brand, including XyliMelts for dry mouth. The deal (terms undisclosed) expands Quest’s oral-care portfolio and is supported by mezzanine and senior debt provided by Avante Mezzanine Partners and MB Financial, with Cascadia Capital advising OraHealth.

ADQ Acquires Acino from Avista Capital and Nordic Capital

September 16, 2021

Pharmaceuticals

Abu Dhabi holding company ADQ has agreed to acquire Acino, a Swiss pharmaceutical company headquartered in Zurich, from private equity owners Avista Capital Partners and Nordic Capital. The transaction supports ADQ's strategy to build a regional pharmaceuticals and healthcare platform, expanding capabilities in manufacturing, commercialization and distribution across emerging markets.

Vision Healthcare Acquires AixSwiss (Nupure)

September 23, 2022

Consumer Products

Vision Healthcare has acquired 100% of AixSwiss BV, the Dutch owner of the fast-growing probiotic nutraceutical brand Nupure, which generated approximately €20m in sales in 2022. The deal strengthens Vision Healthcare’s pan‑European digital omni‑channel VMS and nutraceutical platform and adds probiotic product capability and DACH e‑commerce reach to its portfolio.